分子モデリング市場は、2021年の130億ドルから2031年までに173億ドルを超え、今後数年間、つまり2021-31年のCAGRは13.8％と予想されます。
慢性疾患の発生数の増加が、より高度で効果的な治療法の開発を後押しすることが予想されます。このような状況において、予測期間中分子モデリング市場は予測期間中も拡大し続ける可能性があります。 2021年に発表されたWHOのデータによると、癌は世界で2番目に多い死因です。これは年間1000万人に及ぶ死亡の原因となっています。さらに、肝炎やヒトパピローマウイルス（HPV）などの癌の原因となる疾患は、低中所得国の癌発生率の3分の1以上を占めています。慢性疾患の頻度の増加、および低コストの医薬品の提供における医薬品開発の更なる利点が、分子モデリング業界を前進させています。
目次
Contents
1. Executive Summary
2. Global Molecular Modeling Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Molecular Modeling Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Molecular Modeling Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. Global Molecular Modeling Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By application: Market Share (2020-2031F)
12.2.1. Drug Development, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Drug Discovery, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By product: Market Share (2020-2031F)
12.3.1. Software, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 Company Profile
13.1. Simulations Plus, Inc (US)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Cambridge Crystallographic Data Centre (England)
13.3. Optibrium (UK)
13.4. Cresset (UK)
13.5. BioSolveIT GmbH (Germany)
13.6. OpenEye Scientific Software (US)
13.7. Chemical Computing Group (Canada)
13.8. Acellera Ltd (London)
13.9. Dassault Systèmes (France)
13.10. Schrödinger, LLC (US)
13.11. Certara, L.P (US)
13.12. Other Prominent Players
14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
